Table 3.
Parameter | Number of Patients (n =12) (%) | Mean ± SD (Range) |
---|---|---|
Sex (male) | 7 (58.3%) | |
Mean age at first audiogram (years) | 12 | 8.8 ± 6.1 (0.9–17.6) |
Genotype HbSS | 10 (83.3%) | |
Genotype HbSC | 2 (16.7%) | |
History of cerebrovascular disease | 3 (25%) | |
History of abnormal transcranial Doppler screen | 3 (25%) | |
R. Ear Average Pure Tone Average (dB HL):a | 10 | 43.3 ± 28.9 (13.8–100) |
Normal hearing (< 20 dB HL) | 2 (20%) | |
Mild hearing loss (20–40 dB HL) | 4 (40%) | |
Moderate hearing loss (40–60 dB HL) | 1 (10%) | |
Severe hearing loss (60–80 dB HL) | 2 (20%) | |
Profound hearing loss (> 80 dB HL) | 1 (10%) | |
L. Ear Average Pure Tone Average (dB HL):a | 10 | 40.8 ± 29.7 (8.8–100) |
Normal hearing (< 20 dB HL) | 3 (30%) | |
Mild hearing loss (20–40 dB HL) | 3 (30%) | |
Moderate hearing loss (40–60 dB HL) | 2 (20%) | |
Severe hearing loss (60–80 dB HL) | 1 (10%) | |
Profound hearing loss (> 80 dB HL) | 1 (10%) | |
Absent DPOAEsb | 7 of 9 tested (77.8%) |
Pure tone averages could not be calculated in two patients with SNHL, as at least one hearing frequency was missing from 500 to 2000 Hz.
Counted as absent, if absent at any range within the tested range, suggestive of abnormal outer hair cell function.